What Types of Violations Can Lead to Regulatory Penalties?
Several types of violations can lead to regulatory penalties in the cancer field, including:
1. Non-compliance with Good Manufacturing Practices (GMP): Ensuring that drugs are consistently produced and controlled according to quality standards. 2. False Advertising: Misleading claims about the efficacy or safety of cancer treatments. 3. Clinical Trial Misconduct: Deviations from approved protocols or unethical practices in conducting clinical trials. 4. Data Falsification: Manipulating or fabricating research data. 5. Patient Privacy Violations: Breaches of patient confidentiality and data protection laws.
